Most bought healthcare stocks in Q2 2026
Discover which Healthcare stocks institutional investors added to most aggressively over Q2 2026 versus the prior calendar quarter in our filings. Notable additions at the top of this list include GOSSAMER BIO INC (GOSS), BRISTOL-MYERS SQUIBB CO (BMY), ALLOGENE THERAPEUTICS INC (ALLO), EDWARDS LIFESCIENCES CORP (EW). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GOSS | GOSSAMER BIO INC | 203,796,857 | $5.5M | 31 | 56 | 42 | 46 | 165 |
| BMY | BRISTOL-MYERS SQUIBB CO | 158,985,646 | $12.7B | 179 | 972 | 955 | 223 | 2431 |
| ALLO | ALLOGENE THERAPEUTICS INC | 130,425,074 | $211.8M | 36 | 95 | 46 | 37 | 204 |
| EW | EDWARDS LIFESCIENCES CORP | 103,265,478 | $13.4B | 161 | 451 | 448 | 140 | 1281 |
| VTRS | VIATRIS INC | 86,888,820 | $3.6B | 108 | 352 | 308 | 129 | 982 |
| ALT | ALTIMMUNE INC | 81,021,517 | $243.0M | 63 | 82 | 30 | 24 | 205 |
| MRK | MERCK & CO. INC. | 77,436,118 | $25.8B | 208 | 1579 | 1443 | 221 | 3707 |
| CABA | CABALETTA BIO INC | 70,967,111 | $255.9M | 54 | 48 | 20 | 24 | 136 |
| EDIT | EDITAS MEDICINE INC | 69,598,844 | $261.0M | 39 | 72 | 38 | 34 | 207 |
| CVS | CVS HEALTH CORP | 68,441,562 | $40.7B | 320 | 752 | 709 | 155 | 2003 |
| RLAY | RELAY THERAPEUTICS INC | 61,404,953 | $2.7B | 51 | 104 | 61 | 42 | 245 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 57,576,890 | $4.4B | 88 | 260 | 185 | 78 | 648 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 53,294,682 | $424.8M | 48 | 34 | 14 | 19 | 109 |
| ABBV | ABBVIE INC | 52,759,229 | $77.9B | 278 | 1857 | 1490 | 212 | 4081 |
| JNJ | JOHNSON & JOHNSON | 51,347,608 | $31.9B | 209 | 1996 | 1833 | 235 | 4519 |
| GILD | GILEAD SCIENCES INC | 48,526,001 | -$6.0B | 148 | 916 | 828 | 229 | 2197 |
| BAX | BAXTER INTERNATIONAL INC | 41,865,348 | $3.2B | 102 | 237 | 184 | 92 | 654 |
| LXRX | LEXICON PHARMACEUTICALS INC | 41,736,410 | $371.3M | 44 | 35 | 34 | 33 | 144 |
| UNH | UNITEDHEALTH GROUP INC | 40,761,291 | $119.5B | 514 | 1251 | 1238 | 224 | 3276 |
| AVTX | AVALO THERAPEUTICS INC | 40,217,683 | $849.0M | 57 | 44 | 13 | 29 | 121 |
| ROIV | ROIVANT SCIENCES LTD | 40,124,879 | $5.4B | 102 | 191 | 130 | 55 | 477 |
| AURA | AURA BIOSCIENCES INC | 39,174,395 | $298.9M | 38 | 54 | 24 | 21 | 139 |
| SGMT | SAGIMET BIOSCIENCES INC-A | 37,659,056 | $324.5M | 58 | 35 | 10 | 23 | 121 |
| CCCC | C4 THERAPEUTICS INC | 36,628,852 | $334.6M | 53 | 52 | 26 | 27 | 145 |
| ABSI | ABSCI CORP | 36,320,018 | $1.4B | 56 | 65 | 48 | 19 | 193 |
| TNGX | TANGO THERAPEUTICS INC | 35,186,515 | $2.8B | 74 | 96 | 52 | 30 | 233 |
| TSHA | TAYSHA GENE THERAPIES INC | 34,431,649 | $835.6M | 43 | 95 | 39 | 28 | 203 |
| OCGN | OCUGEN INC | 34,321,604 | $21.7M | 43 | 44 | 25 | 33 | 144 |
| AVTR | AVANTOR INC | 34,094,768 | $1.7B | 99 | 180 | 102 | 82 | 438 |
| ATAI | ATAI LIFE SCIENCES NV | 34,077,958 | $346.3M | 78 | 79 | 27 | 30 | 228 |
| NTLA | INTELLIA THERAPEUTICS INC | 34,056,205 | $1.0B | 55 | 134 | 70 | 37 | 312 |
| PFE | PFIZER INC | 33,707,965 | -$13.3B | 156 | 1128 | 1166 | 313 | 2735 |
| ESPR | ESPERION THERAPEUTICS INC | 31,969,580 | $171.7M | 65 | 44 | 49 | 81 | 185 |
| COR | CENCORA INC | 29,666,784 | $3.9B | 119 | 411 | 593 | 213 | 1300 |
| ALRN | AILERON THERAPEUTICS INC | 29,132,997 | $27.3M | 19 | 19 | 3 | 9 | 56 |
| ALHC | ALIGNMENT HEALTHCARE INC | 28,868,066 | $1.9B | 79 | 139 | 74 | 53 | 312 |
| ELAN | ELANCO ANIMAL HEALTH INC | 28,839,692 | $1.1B | 79 | 159 | 192 | 91 | 497 |
| STTK | SHATTUCK LABS INC | 28,561,643 | $226.4M | 40 | 34 | 14 | 23 | 98 |
| HLN | HALEON PLC-ADR | 28,362,207 | -$110.3M | 89 | 204 | 202 | 81 | 618 |
| ALVO | ALVOTECH SA | 26,615,575 | $102.7M | 24 | 18 | 16 | 8 | 70 |
| ANNX | ANNEXON INC | 26,609,976 | $177.3M | 31 | 74 | 77 | 36 | 208 |
| RXRX | RECURSION PHARMACEUTICALS-A | 26,370,002 | $296.3M | 46 | 122 | 96 | 50 | 326 |
| WRBY | WARBY PARKER INC-CLASS A | 26,302,341 | $1.7B | 66 | 122 | 72 | 70 | 290 |
| LUCD | LUCID DIAGNOSTICS INC | 25,894,690 | $24.9M | 27 | 54 | 12 | 14 | 112 |
| INSM | INSMED INC | 24,990,998 | -$8.0B | 118 | 236 | 216 | 137 | 639 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 23,993,679 | $294.8M | 46 | 92 | 48 | 59 | 208 |
| OSCR | OSCAR HEALTH INC - CLASS A | 23,900,498 | $3.6B | 120 | 129 | 97 | 58 | 381 |
| IBRX | IMMUNITYBIO INC | 22,290,411 | $399.8M | 61 | 135 | 96 | 58 | 382 |
| CNC | CENTENE CORP | 22,117,255 | $16.4B | 222 | 324 | 327 | 102 | 967 |
| SANA | SANA BIOTECHNOLOGY INC | 21,395,871 | $173.4M | 34 | 63 | 59 | 29 | 202 |